How Schwab Network’s view on $LRCX changed

Channel profile →This channel has 36 credited speakers: BFA and JP Morgan, Bank of America, Barclays, Berenberg, Bernstein, with a Jefferies target cut noted, Bird (analyst firm), CEO, Citi, Citigroup, Citizens, Daiwa, Dan Ives, Deutsche Bank, Erit Research, Evercore ISI, Evercore ISI; Dan Ives, Goldman Sachs, JP Morgan Chase, JPMorgan, Jefferies, Jefferies, UBS and Citigroup, Jensen Huang; Dan Ives, Loop Capital, Mattie Natsson, Michael Saylor, Milius (analyst), Morgan Stanley, Northrop, Oppenheimer, Tim Bigham, Tim and KG, Truist, UBS, Wall Street Journal, Wedbush, Wells Fargo2 entries

2026-10-21Bullish

“EARNINGS PANEL: META, TSLA, IBM, LRCX, TXN”

LRCX's quarter looked decent — EPS $2.20 beat by a penny, revenue up 54% to $8.22 billion, systems revenue up 62%, gross margin widened to 52.4% — and guidance is roughly in line; nothing in the numbers justifies the ~6% drop, which may reflect supply-chain and price-increase commentary.

Right now, I want to jump to Lamb Research because they're down about 5.5%. Lamb reporting their first quarter EPS of $2.20. They did have an issue when they first reported that coming across the wire.

That was an incorrect number, but it's 220. It beat the estimates by a penny.

Their revenue rose 54% year-over-year to 8.22 billion. That also topped the estimates looking for 8.13. Systems revenue is at 5.73 billion. That's up 62% year-over-year. also topped the $5.6 billion estimate.

Watch the source06:08

2026-10-16Bullish

“Danielle Shay on Trading NVDA, AMD, AVGO & TSLA into Earnings”

Speaker owns LRCX long term, likes it and wouldn't sell; it performed excellently over two years. But LRCX recently broke support; into earnings after a sharp decline, nervous investors may sell on any slowdown or problem, so short term could be worrying. It jumped 26% last quarter; he will wait for positive reaction.

Yes, I also own this stock in my long-term portfolio, and I like it; it has performed excellently over the past two years. However , I would like to point out again that this is another stock that recently broke the support level .

So, it's a difficult situation when you approach earnings reports with these companies that have declined sharply, because investors get nervous, and when growth slows or there is any sign of any problem, people get anxious and rush to sell the stock.

So, I really like the stock. I personally would not sell it. I keep it in my long-term portfolio, but in the short term, given the breaking of support levels, it could be worrying.

But last quarter, the stock jumped 26% after the earnings announcement. So, we have to wait and see if we will get a positive reaction to this stock.

Watch the source07:21